12.05.2011 • NewsNew ZealandBilanz

Nuplex Says Expects Flat Profit

New Zealand-based resins and chemicals maker Nuplex Industries said on Thursday it expected to report a flat profit for the current year, with higher raw material prices and soft demand in some markets.

Nuplex said its net profit for the June 2011 year would be between NZ$62 million and NZ$65 million ($48.8 million to $51.4 million), compared with NZ$64.2 million in the year to June 2010. The company also said earnings before interest, tax, depreciation and amortization (EBITDA) would be between NZ$125 million and NZ$239 million, lower than previously forecast on restructuring of some of its operations.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read